Hospital director David Walker said: “Ewan Ferguson has been providing our dermatology service for many years and with Hilary joining him, we will now be able to provide a full-time service to support our referring vets, their clients and pets.
He added: “We are really delighted that Hilary is joining the dermatology team at Anderson Moores. Her passion for dermatology is infectious and with a particular interest in chronic ear disease, I’m sure she’s going to be very busy!”
Hilary has been a past Board member and organiser of the scientific meetings for the British Veterinary Dermatology Study Group, a member of the In Practice editorial board for 20 years and a past chief examiner for the RCVS Small Animal Medicine Certificate. She continues to act as a mentor for the BSAVA PGCertSAM course and as an assessor for the RCVS Advanced Practitioner in Small Animal Dermatology.
Hilary has worked in first opinion and referral clinics around the south west, including running her own dermatology referral service within several veterinary practices. From 2018 to 2021, she had been working as lead clinician in dermatology at Langford Vets (University of Bristol).
Hilary said: “I’m very excited to be joining the fantastic team at Anderson Moores and really looking forward to helping make a difference with the new dermatology service we’ll be offering.
For more information, visit www.andersonmoores.com.
The ‘2022 AAFP/ISFM Cat Friendly Veterinary Interaction Guidelines: Approach and Handling Techniques’ and the ‘2022 ISFM/AAFP Cat Friendly Veterinary Environment Guidelines’ cover all aspects of a cat’s veterinary experience, including the journey to the practice and interactions with veterinary team members, as well as the clinical environment.
The new guidelines cover things like:
Dr Nathalie Dowgray, Head of ISFM (pictured right), said: "We are extremely proud of our new guidelines; they have been a lot of hard work with large amounts of literature to review and multiple time zones to work across, but the effort has been worth it.
"We hope all veterinarians working with cats will take the time to read them and apply the concepts and ideas to their clinics and to how they personally interact with their feline patients.’
The guidelines are available at: https://journals.sagepub.com/page/jfm/collection/cat-friendly-special-issue
Ceva Animal Health has produced a new advisory leaflet about enzootic abortion control and vaccination strategy in sheep to help vets explain the best prevention protocols to clients.
According to the company, it is estimated that around half of the 400,000 infectious abortions in UK sheep each year are from enzootic abortion caused by Chlamydophila abortus, but timely vaccination programmes can prevent such dramatic losses.
The eight-page leaflet explains how enzootic abortion can spread, why prevention is better than cure, the importance of timely vaccination of ewe lambs and replacement stock, how vaccination programmes make good economic sense and the benefits of using Cevac Chlamydia, Ceva Animal Health's live enzootic abortion vaccine as part of the control programme.
Carol Atkinson, reprodAction's product manager said: "Cevac Chlamydia receives consistently good feedback from vets, many of whom have enthusiastically volunteered their praise for the product to our territory managers. We thought a leaflet would be a constructive way to share views, giving vets the chance to hear about the advantages of vaccination and to provide them with the tools to explain to their clients why vaccinating against enzootic abortion is cost worthy."
For further information contact Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
World Horse Welfare and Federation of European Equine Veterinary Associations (FEEVA) have announced the publication of a new set of practical guidelines on assessing the fitness for transport of equidae (horses, ponies, donkeys and their hybrids).
The publication was produced by a collaboration of agri-food, transport, veterinary organisations and animal welfare groups supported by the European Commission.
The guidelines are designed to set out clear and simple methods of assessing the fitness of equidae for transport to support a number of objectives including: helping maintain good health among animals and humans, reducing the risk of disease transmission and preventing animal suffering. The guidelines also support transporters in avoiding penalties, financial losses, and withdrawal of the transporter’s authorisation or driver’s certificate of competence.
The guidelines also offer a health and transport checklist and a quick reference guide to assess vital signs and health concerns.
Whilst the guidelines have been produced to protect animal welfare, they also aim to help protect the health and safety of anyone involved in the transport of equidae, supporting transport professionals in the enforcement and understanding of EU Regulation 1/2005 which states that 'No animal shall be transported unless it is fit for the intended journey'.
Andrea Gavinelli, Head of Unit for Official Controls and Eradication of Diseases in Animals, said: "These guidelines will be an essential resource for anyone involved in the transportation of horses, donkeys, mules or their hybrids and I am pleased that the Commission has been able to support their production and dissemination."
The guidelines also received recognition from Dr Bernard Vallat Director General of the World Organisation for Animal Health (OIE) for 15 years before recently leaving the position. He said: "It is my pleasure to commend this visual guide to health conditions that may impact on the fitness of animals to travel. This clear and simple guide will help all those involved in animal transport to quickly and easily assess the situation and understand what course of action to take."
The guidelines are available by registering via FVE (Federation of Veterinarians of Europe) www.fve.org
Vétoquinol has announced plans to raise £10,000 for The Blue Cross pet charity through sales of Propalin, its fast acting treatment for incontinence in dogs.
From 1st July to 31st December this year, for every 100ml bottle of Propalin ordered, Vétoquinol will give 18p to The Blue Cross and 7p for every 30ml bottle.
To boost the amount raised for The Blue Cross, Vétoquinol is offering vets a free bottle of Propalin for every six bottles ordered of both the 100ml and 30ml sizes.
For example, if you order 18 100ml bottles of Propalin, you will receive 6 free bottles and The Blue Cross will receive £4.32.
Vanessa Rossiter, corporate fundraising officer for The Blue Cross said: “As a charity, The Blue Cross relies on donations to support our adoption centres and animal hospitals around the country. We are very grateful to Vétoquinol for their pledge to raise funds for the hundreds of needy animals in our care.”
According to Vétoquinol, Propalin is the UK’s best selling licensed veterinary treatment for urinary incontinence in the ***. It contains phenylpropanolamine hydrochloride, which acts to increase the tone in muscles that make up the urethal sphincter. It takes effect within 30 minutes of administration and, as a liquid, is highly palatable.
RCVS Knowledge has announced the official launch of Veterinary Evidence – a new resource designed to unite practitioners interested in promoting and using the principles of evidence-based veterinary medicine (EBVM) within practice.
Veterinary Evidence – which is supported by the RCVS – represents RCVS Knowledge’s wider mission statement of providing the veterinary community with practice relevant, evidence-based information resources. Papers and publications are now available for use, completely open-access.
Veterinary Evidence aims to become the go-to portal for evidence-based veterinary information, promoting and publishing peer-reviewed papers alongside discussion of EBVM through opinion, clinical and methodological articles.
The site will host a wide range of material – from randomised controlled trials to case studies, Knowledge Summaries and interviews. The content is designed to educate readers in research techniques, responding to the desire amongst many veterinary professionals to become involved in effective practice-based research – including critical appraisal and clinical audit.
Jacqui Molyneux, Chair of the RCVS Knowledge Board of Trustees said: "As a practising veterinary surgeon I, along with many others, recognise the emerging importance of evidence-based veterinary medicine and I believe it will become more and more important as time goes on. We all wish to do the best for our patients but how do we find out what the current ‘best’ is? That’s where this portal will become so useful; collecting and publishing articles that directly help practising vets and nurses to answer that question."
Bradley Viner, the President of the RCVS and a Trustee of RCVS Knowledge, said: "The College was very happy to support our charity partners at RCVS Knowledge in launching this excellent new resource which will be relevant to all veterinary surgeons and veterinary nurses in clinical practice. Furthermore, clinical governance is now firmly established as an important principle in the Code of Professional Conducts for both professions and so, by encouraging practitioners to undergo a continuing process of reflection, analysis and improvement, Veterinary Evidence will also be helping them fulfil their professional responsibilities."
Access the full site at: www.veterinaryevidence.org
She said: "The veterinary family – which is my focus as BVA President – is part of the international scientific community, and we are a diverse profession with far-reaching influence and impact in so many areas of political and public life ... A healthy veterinary workforce is vital for UK animal and human health."
With the residence or working rights of UK-based EU vets a 'top five' priority for the profession in forthcoming Brexit negotiations, Gudrun highlighted workforce issues: "The UK veterinary profession relies heavily on EU graduates, who have felt the impact of the EU referendum result since day one … In the meat hygiene sector alone, some estimates suggest 95% of veterinary surgeons graduated overseas.
"That’s why our first action after 23 June was to call on UK governments to protect the status of EU veterinary surgeons and veterinary nurses currently living and working in the UK. It was encouraging to see some of these key priorities … make it into the Prime Minister’s list of negotiating priorities. But we have said from the outset that our members need certainty and reassurance, so we urge the Government to make that firm commitment now."
"We know vets remain nervous about the changes to come, with many of our members concerned about the threat Brexit poses for UK animal health and welfare … Yet we can also see the opportunities Brexit presents, and BVA is determined to work with the Government to seize these opportunities, where they exist, to improve standards."
Highlighting opportunities that Brexit could offer in terms of improving animal health and welfare, Gudrun suggested a tightening up of the Pet Travel Scheme to reduce the growing trend of illegal puppy imports and improvements for welfare at slaughter. She said:
"The Welfare at Time of Killing or WATOK Regulations for England … are a case in point about the welfare-mismatch that could occur between domestic standards and those of our trading partners under the new Brexit arrangements. By failing to bring in evidence-based parameters for all waterbath stunning of poultry, [the] legislation has rendered it impossible for Official Veterinarians to protect the welfare of all chickens at slaughter. The regulations are simply not for fit for purpose, and could call into question England’s claim as a leader in high animal welfare."
The BVA President then shared a highlight of an early meeting between BVA and the then new Defra Secretary of State Andrea Leadsom MP last July: "We were pleased to hear [the Defra Secretary of State’s] vision to make the unique selling points of 'UK PLC' high animal welfare and food safety standards. It's a commitment that BVA fully backs ... To ensure our high standards continue, it is essential that we maintain existing veterinary certification and controls to satisfy our own consumer demand for quality and safety. Official statistics put the value of UK livestock outputs at £13 billion and not a penny of that could be realised without veterinary input."
Gudrun concluded by saying: "We can only make a success of Brexit if we harness our veterinary resource in clinical practice, public health, government services, conservation, academia, research and industry. We are a small profession but our impact is significant."
The Parliamentary Under Secretary of State for Rural Affairs and Biosecurity Lord Gardiner of Kimble responded, saying: "In my role at Defra I am continually reminded of the importance of the relationship between vets and government - most recently in tackling the outbreak of Avian Influenza in the UK. Your thoughts and ideas are invaluable as we manage the many opportunities and challenges posed by exiting the European Union, ensure the highest standards of animal welfare, protect the country from new animal disease threats, and attract the brightest and best into the profession.
"I look forward to continuing to work closely together as we push ahead with our plans to create a world leading food and farming industry based on high standards of animal health and welfare."
To find out more about the BVA’s work on the UK’s exit from the EU, visit www.bva.co.uk/news-campaigns-and-policy/policy/future-of-the-profession/brexit/
According to the company, information on best worming strategies for foals and yearlings remains largely anecdotal, making it difficult to develop a clear plan for this age group. Zoetis veterinary surgeon Wendy Talbot has therefore reviewed the recent literature to develop an eight-point plan.
Explaining the guidance, Wendy writes:
Foals and yearlings are usually more susceptible to worms than are adult horses because they have had little chance to develop any immunity. They are more vulnerable to related diseases and tend to have higher egg shedding, which increases the risk of infection. The main parasitic culprits in the UK for foals less than six months of age are large roundworms (ascarids). In older foals and weanlings, small and large strongyles, tapeworms (and pinworms) are the main considerations.1 Yearlings may also have a second wave of large roundworm infection at 8-10 months of age.2 Any control strategy will need to take into account the individual circumstances such as stocking density, pasture management and previous disease history.
Guidelines for parasite control in foals suggest a first treatment with fenbendazole at 2-3 months of age, targeting large roundworm, followed by another treatment at 5-6 months. Alternatively, pyrantel may be considered for these doses; however, there may be resistance in some areas and foals with large adult ascarid burdens may be at higher risk of intestinal rupture when this drug is used.4 At weaning (approximately six months of age), it is advisable to perform a faecal worm egg count (FWEC) to determine if treatment for strongyles is also required; the macrocyclic lactone anthelmintics (ivermectin or moxidectin) are expected to have the highest efficacy. At 9 and 12 months of age treatment for stronglyes and a larvicidal dose for encysted stages of small strongyles (moxidectin or a 5 day course of fenbendazole) are indicated. A tapeworm treatment should be included with one of these doses.2,3
For yearlings, two methods have recently been proposed for worm control: the first involves using faecal worm egg counts (FWECs) at more frequent intervals than for adults to guide dosing for strongyles in the grazing season.1 The second suggests three baseline treatments targeting strongyles in spring, summer and late autumn, with FWECs in between to identify and treat any still shedding high numbers of eggs, up to a maximum of six treatments per year.2 Macrocyclic lactones have the highest expected efficacy against small strongyles and should form the basis of treatments; however, pyrantel can be considered for some treatments where it has been shown to have continued efficacy. Both strategies include a larvcidal treatment for encysted small redworm combined with testing or treating for tapeworm in late autumn. The inclusion of one or two doses of a macrocyclic lactone each year (usually already used for small strongyle control) should be sufficient to prevent large strongyle related disease.3
The wide differences in the circumstances of foals and yearlings, together with geographical variations in resistance patterns and a lack of consensus on best practice in this group means it is not possible to define a single approach to a worming plan. An important point to note is that FWECs may give surprising results because higher counts are generally seen in youngstock.
Eight ways to keep clients' youngstock worms controlled:
For further information on worming together with some equine specific CPD visit: https://blog.vetsupportplus.com/
Julia, who is a leading exponent of the Brainstem Auditory Evoked Response (BAER) screening test, will also support the small animal referral hospital’s neurology, ophthalmology and dermatology teams with enhanced diagnostics.
Julia was a neurology technician at the Animal Health Trust for 31 years, until it closed in July 2020. With colleagues there she helped to develop and implement BAER testing as a screening process in animals at risk of congenital deafness. Davies says this is now recognised as the gold standard in deafness testing by organisations such as The Kennel Club and various breed clubs in the UK.
Julia said: “I am so happy to be starting a new chapter at Davies. It is really exciting to be establishing the Hearing Assessment Clinic here and continuing to provide this important service both to previous clients and new ones. I am also looking forward to developing a successful, constructive working relationship with my new colleagues."
Tim Richardson, Managing Director of Davies said: "We are delighted to welcome Julia to the team at Davies. As one of the UK’s leaders in this highly specialised field she enables us to offer hearing screening, hearing tests and electrodiagnostics across the relevant disciplines, at the very highest level."
For further information visit www.vetspecialists.co.uk
For the study, 21 owners were interviewed and transcripts thematically analysed.
Owners who reported positive experiences with their vets described the value of comprehensive initial explanations of their dog’s condition, seeing the same veterinary surgeon for each consult, and individual attributes of vets, including current knowledge on epilepsy management and good communication skills.
The authors say these factors are likely to contribute to improved two-way vet-owner communication, owner satisfaction and adherence to care instructions.
The implications of a negative relationship were also highlighted by the study.
Owners’ dissatisfaction with perceived insufficient expertise from their general practice vet (resulting in referrals to specialists), and when referred, poor communication between referral specialists and their primary care vet.
Owners’ pre-existing views and values were identified as drivers of negative experiences including strong dog-owner bonds leading to extremely high expectations for veterinary care.
Another factor was pre-existing distrust and perceived biases of the veterinary pharmaceutical industry.
Owners who had a more negative experience with veterinary surgeons were found to be more likely to perform their own personal research, putting them at higher risk of being influenced by the large amount of misinformation online.
The authors say that vets often report that they find epilepsy challenging to manage, particularly as a high proportion of dogs do not respond sufficiently to available medications.
This study aimed to help provide a better understanding of owners’ wants and needs.
Dr Rowena Packer, Primary supervisor on this study and Lecturer in Companion Animal Behaviour and Welfare Science at the Royal Veterinary College, said: “Epilepsy is a challenging condition to manage for dog owners and veterinary surgeons alike.
"Owners’ emotions often run high due to the trauma of witnessing their beloved dog’s seizure, and the ongoing stresses of caregiving for their dog.
"In tandem, vets can feel frustrated at not always being able to reduce seizures as much as they’d hope.
"Combined, the capacity for disappointment and conflict is high.
“Forging strong, trusting partnerships of care between owners and vets is key to maintaining wellbeing for all three members of the ‘treatment triangle’ – affected dogs, owners and vets."
Amy Pergande, Royal Veterinary College Veterinary graduate who conducted this research as part of her Master of Research degree, said: “Improving availability of reliable information sources for epilepsy management could help veterinary teams to confidently prescribe ’information prescriptions’ that boost owner confidence and help them to feel empowered to contribute more actively in decision-making for their dog, in partnership with their vet.”
Dr Zoe Belshaw, EBVS Recognised Specialist in Small Animal Medicine, of EviVet Evidence-based Medicine Research Consultancy and co-author of the study, said: “Our research suggests owners really value vets taking the time, once the initial shock has receded, to share information, answer questions and signpost to external resources, including peer-to-peer support forums.
"Ensuring that owners feel confident and competent about caring for their dog with epilepsy is likely to benefit the dog, its owners and the veterinary team providing their ongoing care”.
Snowflake previously had a squamous cell carcinoma mass on the right lower eyelid, which was completely removed in 2018.
However, her owner noticed an abnormal growth in the left eye, and brought her back to the RVC.
On presentation, Snowflake was bright and in good body condition, weighing 71kg.
Both eyes were open and appeared comfortable and visual.
Ocular reflexes and responses were also present as expected and there was no evidence of recurrence of the squamous cell carcinoma on the lower right eyelid.
Snowflake was, however, diagnosed with mild cataracts in her right eye deemed unlikely to interfere with her vision.
In addition, the mass of her left third eyelid was nonpigmented and displayed a poorly defined mass-like lesion, with an irregular surface on the leading edge, appearing consistent with a squamous cell carcinoma.
The team, led by Dr Maria-Christine Fischer, Lecturer in Ophthalmology, Dr Sara Lawrence-Mills, Senior Clinical Training Fellow in Anaesthesia, and Dr Carolina Palacios Jimenez, Lecturer in Anaesthesia, decided to undertake surgery.
They removed the third eyelid under sedation and applied local anaesthetic blocks and topical tetracaine eye drops.
Cryotherapy was then applied to the wound edge as an adjunctive therapy.
The RVC says that to date, there are few publications detailing anaesthesia in reindeer and so this protocol was a novel approach to maintaining a safe level of sedation in a well-domesticated animal.
The College added that the use of these nerve blocks to facilitate ophthalmic surgery has not been reported before and is in the process of being published.
Snowflake’s third eyelid was submitted for histopathology, which confirmed the diagnosis of squamous cell carcinoma, which the team at the RVC was able to remove completely.
During the process, Snowflake’s daughter was with her so they both remained calm, and she has now made a full recovery and has enjoyed being reunited with her herd.
Maria-Christine said: “Snowflake had a cancerous mass on her third eye lid.
"Surgical removal of the third eyelid in a reindeer has not been reported before.
"We were pleased that we could perform the surgery with Snowflake under a standing sedation and with using local anaesthetics.
"As an ophthalmologist, I am committed to preserving vision so it’s rewarding that we were able to completely excise the tumour and did not have to remove the eyeball. It’s a very good outcome.
"I’m also pleased that Snowflake recovered quickly from the procedure, and we were able to share the protocol of the sedation and the local nerve blocks with other vets via a scientific publication.
"Sharing our knowledge will hopefully be beneficial for future ophthalmic surgeries in reindeer.”
* aka Mr Nick Dean.
Success in Veterinary Practice by Dr. Bradley Viner DProf BVetMed MSc(VetGP) MRCVS is now available from Wiley Blackwell at £28.99. Teeside general practitioner Rob Reid BVM&S MRCVS has reviewed the book for members of VetSurgeon.org:
There are many self-help books available in a variety of fields, covering topics which range from stress management and emotional control through to furthering one's career and professional development. Until now, there has been no such publication that has covered these issues in the veterinary context, and it is here that Bradley Viner has identified a niche in the market with his new book Success in Veterinary Practice.
The aim of book is to help veterinary practitioners of all levels to develop and nurture their professional skills, both on a personal and at a practice level. The book will be of interest to vets in all fields and contains a lot of information that will be particularly relevant to vets who are embarking on the Professional Key Skills Module of the RCVS CertAVP. It may also be of interest to other members of the veterinary practice team and is also marketed at individuals who are considering a career in the veterinary field.
The book is organised into nine chapters, with the first eight providing content matter on areas such as personal development, communication techniques, improving clinical performance and developing leadership skills, with the final chapter summarising the information presented. The first eight chapters are structured in such as way that information is presented in a digestible format. The material is detailed enough to provide understanding without being overburdening and the summary and exercise sections presented at the end of each chapter help the reader to review what they have read and pick out the key ideas.
There were many areas of the book I found interesting and I liked the way that the author has looked at the psychological and sociological aspects of one's actions, both in relation to colleagues in the workplace and in relation to dealing with clients. From a personal point of view, I also liked the section on communication skills - an area which probably doesn't receive enough coverage in both undergraduate and postgraduate education.
On the negative side, there are some minor typographical errors and I feel some of the diagrams could have been better produced. The pure academics among us may also be somewhat critical about the author's stance towards the relevance of some aspects of clinical research. And of course some people may be put off by the price, with the truly cynical among us possibly seeing the close relevance of the content to the syllabus of the CertAVP 'A' module as a cunning marketing ploy!
As a general practitioner, however, I found the book to be informative and thought-provoking. I have found it has encouraged me to take a look at certain aspects of my work which I have almost done instinctively in the past, analyse my reasons for doing them and then look at how I can improve on these in the future, for the good of patients, my clients, the rest of the working team and of course for myself. It is certainly an interesting read, and I would recommend it to be of value to any vet who sees the term 'professional development' to mean far more than a simple sharpening of one's clinical skills.
Dechra Veterinary Products has produced a pair of presentations, aimed at pet owners, for vets to use in receptions and at client events. The presentations cover canine hyperadrenocorticism, aka Cushing's syndrome, and feline hyperthyroidism.
Matthew Olsen, Product Manager, said: "We are committed to delivering a wide range of support materials and tools to enable vets to provide help and information to their customers. We have developed an owners' booklet on both Cushing's and hyperthyroidism and have now backed this up with PowerPoint presentations for vets to use with their clients. Some veterinary practices are using technology to revolutionise waiting room displays and we have responded to their needs by producing a presentation they can use on their waiting room information screens."
The Dechra Hyperadrenocorticism presentation covers what Cushing's is, what causes it and what owners need to look for. The presentation also explains the treatment options available. The Hyperthyroidism presentation details what the condition is and gives information on the thyroid gland. It highlights what cat owners need to look out for, including weight loss in spite of a ravenous appetite, increased fluid intake and increased restlessness. The presentation also advises people of what to do should they suspect their cat has hyperthyroidism and what the treatment options are.
Garden Lodge Veterinary Clinic in Holywood, County Down, has used the Hyperthyroidism presentation at both its practices. Partner Tom Fitzsimons said: "We have used the presentation on our reception information screens. The presentation has raised owners' awareness and shown them it is a manageable condition. It's led to an increase in the number of cats we are now testing for Hyperthyrodism. We also plan to run the Cushing's presentation in the future."
Veterinary Practices interested in getting hold of a free copy of the Hyperthyrodism and Hyperadrenocorticism presentations should contact Matthew Olsen at Dechra on 01743 441 632 or email matthew.olsen@dechra.com
Rabbit Viral Haemorrhagic Disease variant (RVHD2) is a variation of the already recognised Rabbit Viral Haemorrhagic Disease (RVHD1). Vaccines for the original strain of RVHD do not appear to offer long term protection against RVHD2, however vaccines for this new strain are now available in the UK and can be purchased through three UK wholesalers (NVS, Centaur and Henry Schein Animal Health) or direct from the suppliers in Europe. There have been supply issues with this vaccination, however these are hoping to be remedied soon.
RVHD2 is more variable in its rate of disease progression than RVHD1, with presentation ranging from sudden death (with or without bleeding from the orifices), to a longer disease course of three to nine days, increasing the risk of unwell rabbits being brought into practices and in turn increasing the risk of transmission to other pet rabbits. Until vaccination becomes more routine, biosecurity in practices is key to prevent the disease from spreading.
Sean Wensley, BVA President, said: "Although the risk of a rabbit contracting RVHD2 appears highest in situations where rabbits are kept in large groups with regular new additions, such as at breeders or rescue centres, we encourage all owners to speak to their vet about vaccinating their rabbits against RVHD2.
"Veterinary advice from The Rabbit Welfare Association and Fund (RWAF) has stated that the spread of RVHD2 may be facilitated by its apparent slower disease progression compared to RVHD1, and research suggests that we can expect to see RVHD2 starting to predominate in the UK’s wild rabbits over RVHD1 in the next five years or so."
John Chitty, BSAVA Vice President, said: "BSAVA would encourage practices to talk to rabbit owning clients about RVHD2 vaccines, and where there is deemed sufficient risk recommend the vaccine along with the essential vaccination against Myxomatosis – and it should be noted that this must not be done within two weeks of vaccination against RVHD2."
BVZS President and veterinary pathologist Mark Stidworthy said: "It is clear from post mortem examinations and PCR testing over the last 18 months that RVHD2 is now geographically widespread in the UK and all rabbits should be considered at risk from this potentially devastating disease."
Due to recent media coverage of RVHD2, vets may be contacted by concerned owners seeking advice on how to prevent their rabbits contracting this disease - further to vaccinating, vets should recommend rabbits are kept separate from any other rabbits they do not usually interact with; are prevented from having contact with wild rabbits and do not attend any rabbit shows unless already vaccinated.
For a detailed Q&A on RVHD2 from Richard Saunders MRCVS, veterinary advisor to the RWAF, including information on sourcing effective vaccines, visit www.rabbitwelfare.co.uk and click RVHD2 - Filavac Vaccine – FAQs on the home page.
Photo: Larry D. Moore CC BY-SA 3.0.
Procanicare contains three canine-specific strains of Lactobacillus bacteria, which the company says are proven to improve stool consistency, accelerate recovery following acute episodes of diarrhoea and improve well-being.1
The company also points to a number of studies which it says are evidence of the importance of supporting puppies' intestinal microbiomes.
'New puppy diarrhoea' is, it says, typically due to exposure to factors that are known to risk microbiome disturbance, such as diet change and going to a new home, at a time when the microbial population is at its more sensitive.2
Animalcare says other studies show that microbiome disturbances in early life can have a significant impact on health in adulthood.2,3
James Beaumont, Marketing Manager at Animalcare said: “We often hear from breeders, new puppy owners and vets that puppies which have had Procanicare seem brighter, have firmer stools and less flatulence. With the evidence mounting that the adult intestinal microbiome is shaped in early life and knowing the important and varied role that it has in wider health throughout life, we want to help vets proactively support the GI health of their youngest patients by providing Procanicare for them to trial, with no risk.”
References
The new GPCert programme, led by course director Owen Davies MA VetMB MVetMed MANZCVS (Small Animal Medicine) DipACVIM (Oncology) (pictured right), consists of 12 modules covering key clinical subjects in veterinary oncology delivered over 14 months.
Each module consists of nine lessons, two case studies, course notes and weekly summary videos.
Lessons are supported by notes and videos, quizzes and a forum tutored by leading specialists.
Owen said: “Half of all canine cancers are treatable if caught early enough and new treatments are continuously being researched.
"The programme will guide delegates through the latest knowledge in state-of-the-art, compassionate cancer care for animals, helping them to provide safe and comprehensive diagnostics and treatments.”
For more information, visit: https://www.improveinternational.com/uk/course/oncology-online-learning/
Identichip says the scanner is particularly suited to noise-sensitive dogs and cats.
It's designed to fit in one hand, and is compatible with all ISO 15-digit (FDX-B) microchips.
Tammie O’Leary, commercial lead at Identicare, said: “With compulsory microchipping coming into effect for owned cats from 10 June in England, it is likely that more cats will be presented to check for a chip or to be implanted.
"Many practices are making substantial efforts to minimise fear or stress in their patients, however most microchip scanners beep when they locate a microchip, which can be stressful for animals.
"The silent microchip scanner will help reduce any associated stress for noise sensitive animals.”
Dr Ellie Lee, veterinary surgeon and director at Manchester Cat Clinic, has trialled the silent microchip scanner.
She said: “The scanner is a great tool; we really like how compact it is, which makes it less intimidating for cats, and the silence is definitely beneficial to them too.
"As it doesn’t beep, we watch the screen to check that a chip has been detected, but this is easy to do as it’s such a handy size.”
The silent scanner can be purchased from NVS, Covetrus or from identichip direct.
Questions: contact@identichip.co.uk.
Dechra Veterinary Products has launched four new care products, enhancing its Professional Care range, available exclusively through veterinary practices.
The new products are:
Brand Manager Rachel Horton said: "At Dechra we're focused on providing a complete care solution for companion animals. Our Professional Care range provides products which owners can use at home to keep their pets in great condition.
With the launch of these new products, we believe the Professional Care range provides a cost-effective care solution for pet owners while providing significant additional revenue opportunities for practices."
Dechra Veterinary Products has launched Rycarfa carprofen tablets for dogs and injection for cats and dogs into its Veterinary Essentials range.
Dechra's Veterinary Essentials range comprises a series of post patent products designed to offer practices the reassurance of proven, quality solutions to meet their everyday clinical needs.
In its flavoured tablet form, Rycarfa is presented in easy-to-dispense blister packs which, according to Dechra, offer the most cost-effective standard size range on the market* - 20 mg x 100 tabs; 50 mg x 100 tabs, 50 mg x 500 tabs, 100mg x 100 tabs. The tablets are licensed in dogs for the reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease, and as a follow up to parenteral analgesia in the management of post operative pain.
In injection form, Rycarfa is provided as a 50mg/ml solution in a 20 ml glass vial. In dogs it is indicated for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intraocular) surgery. In cats, it is indicated for the control of post-operative pain following surgery.
Roger Brown at Dechra said: "Carprofen is a well-established, non-steroidal anti-inflammatory. Through our Veterinary Essentials range, we are offering Rycarfa in a wide range of sizes to provide the maximum flexibility with cost effectiveness."
For further information on Rycarfa, please contact Dechra on 01939 211200.
*Gfk sales data 1 July 2011
Modules for the first GPAdvCert – in Small Animal Orthopaedics – will begin in February 2018. Improve says it's the first of many 'next steps' programmes which it plans to launch under this new postgraduate level qualification.
The GPAdvCert in Small Animal Orthopaedics is aimed at veterinary surgeons who have completed their General Practitioner Certificate in Small Animal Surgery (GPCert SAS) or Postgraduate Certificate (PgC) in Small Animal Surgery.
Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and validated by Harper Adams University, the programme is delivered over 15 modules in three state-of-the-art European training centres - Sheffield, UK, Cremona, Italy and Madrid, Spain. Improve says delegates will learn from world-class clinicians and will be supervised in their practise of new surgical techniques and advanced procedures in a wet-lab environment.
David Babington MRCVS, Managing Director of Improve International (pictured right), said: "We felt there was a gap in the current structure for a postgraduate qualification which would allow students to advance their knowledge and practical skills in their chosen area and to add to their academic credentials. The General Practitioner Advanced Certificate is our solution."
Successful achievement of the GPAdvCert will enable delegates to progress from a Postgraduate Certificate in Small Animal Surgery (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Masters Degree (MSc) in Advanced Veterinary Practice Sciences.
David added: "Delegates for our first GPAdvCert in Orthopaedics for Small Animals will enhance their skills and confidence in dealing with more advanced orthopaedic procedures in-house and this will help them to reduce the number of patients which are referred, retaining a higher level of income for their practice. They will also develop skills which they can pass onto their team. We look forward to welcoming our first delegates next year."
Further details are available at: https://www.improveinternational.com/uk/course/general-practitioner-advanced-certificate-in-small-animal-orthopaedic-surgery/
The Society of Practising Veterinary Surgeons (SPVS) has published advice to help practitioners set realistic and reasonable script fees for POM-V medicines.
The document, which is now available to all practitioners via the SPVS web site (www.spvs.org.uk) or can be emailed or posted upon request, has been produced following extensive consultation with SPVS members, principally via the Society's active and influential discussion list, and in conjunction with the BVA Medicines Group, which backs the advice.
The document constitutes a valuable framework for practitioners in calculating a prescription fee that is fair and workable for clients wanting a written prescription as well as for those who do not want a prescription issuing. Furthermore, it also provides a framework that is fair to practitioners themselves.
The Society firmly believes that the act of preparing and providing a prescription is a professional service and as such, that it should attract a professional fee.
Richard Hillman, SPVS President, explained: "We welcome whole-heartedly the re-introduction of prescription fees, which will mark the end of a bureaucratic and fundamentally unfair sitituation for many thousands of small businesses that have had their trade and profitability restricted for three long years.
"The time element involved in writing subscriptions will need to be taken into account, and this will no doubt form a sensible basis on which to base a fee. Script fees should be calculated rationally to reflect true business costs, like any other service that a business provides to its customers."
He added: "We would, above all else, urge practitioners to exercise restraint in setting script fees, as it is by no means certain that they will still be in place even two years from now. We will also not condone any form of 'punishment' of clients taking away prescriptions by punitive fees. We are already cooperating with the RCVS as they work with the OFT in the monitoring period to ensure that there is fair competition in the veterinary medicines market."
To obtain your copy of the document Advice on Prescription Fees, go to www.spvs.org.uk where it can be downloaded or call SPVS Secretariat on 01926 410454 or email office@spvs.org.uk.
Eilona's is one of 50 new jobs created by the company in the last 12 months alone, across a range of positions including veterinary surgeons, nurses and client care co-ordinators.
Eilona said: "White Cross Vets has an unrivalled reputation for offering exceptional pet care, as well as being recognised as a great place to work, which really appealed to me. To become the group’s 200th employee is fantastic and I’m really looking forward to the opportunities and challenges that lie ahead."
Tim Harrison, Managing Director of White Cross Vets, said: "Welcoming 50 new team members into the White Cross family in the last 12 months is a major coup and we’re delighted to have created a 200 strong team with Eilona’s appointment. We are already planning to expand our team further over the coming months, with three new practices due to open before the end of this year, which makes it a very exciting time for us."
Speakers include Dr Ian Stroud, founder and veterinary director of Pet People, an independent small animal practice in Richmond, South West London, Jack Peploe, a veterinary IT expert and Certified Ethical Hacker, and Ciaran Milford, ezyVet’s EMEA sales manager, who has worked with every type of veterinary practice, from aspiring independents right through to established universities and corporate groups.
Lance Rice, creative director at ezyVet, who will moderate the webinar, said: “This webinar is for anyone who feels as though they’ve gone as far as they can in a senior vet or clinic director role, and thinks it might be time to follow their dream of opening their own practice.
“Our speakers are all vastly experienced and ideally positioned to explain what makes a successful launch, as well as the key mistakes and common traps that new owners fall into.
"Ian has a unique understanding of the challenges and opportunities involved with starting a veterinary practice.
"Jack is an expert in helping practices leverage technology to save time, whilst delivering exceptional patient care and bolstering their security posture.
"Ciaran is passionate about helping practices find the right solutions for their needs and business goals."
To register, visit: https://www.ezyvet.com/webinar/starting-a-vet-practice-uk
The story of ‘Spliff' the Staffy has clinched the title of the National Office of Animal Health nationwide search for the most striking ‘it shouldn't happen to a pet' anecdote. Submitted by Vets4Pets in Grimsby, the practice will receive a prize of £500 towards the staff Christmas party.
In a campaign to raise awareness of the importance of animal health and welfare considerations amongst pet owners and potential owners, NOAH has recently launched the new Pet Health Information website (www.pethealthinfo.org.uk) to enable them to make informed decisions about their pet's healthcare.
In Spliff's case, the website could have helped solve a number of queries. For Spliff it all started with a visit to the vet for a minor operation to cure a simple earache.
The problems started as Spliff was about to leave the practice, with a shiny new bucket collar. However, his owner explained that Spliff is a bit of a snappy dresser, and if it isn't bling, he's not interested. Despite the practice's advice, he insisted the collar was removed so he could take Spliff home to recover.
The very next day, the phone started ringing ‘Spliff's scratching his ear - we need a collar.' Far too busy to bring him round, the owner sent his girlfriend to pick it up.
Problem solved - surely? Nope. The phone continued to ring. Spliff was ‘going nuts!' Apparently the dog was unable to walk, and was getting very distressed.
Finally, after nearly 24 hours of increasingly frantic calls, Spliff's owner brought him in. He arrived insisting that the vet came out to the car, as Spliff still couldn't walk. Not a common side effect of a minor operation on the ear, so it was a worry.
All became very clear when the vet reached the car, the ear was healing up nicely, and Spliff's paralysis was easily solved. They had put his bucket collar on the wrong way round, and every time he took a step - his front feet got trapped in the collar.
Rather than collapse in a heap, Spliff, in one of the first sensible decisions of his life, chose not to move at all. Mystery duly solved, Spliff went on to make a full recovery.
Sounds like the owner should probably smoke a bit less of it.
The company says that with an estimated 3.2 million UK households welcoming a new pet into their family home during lockdown1, many experienced and new dog owners will be unaware of the risks to their dog of CCC when it socialises, hence the new risk assessment tool, which is available at: https://www.msd-animal-health-hub.co.uk/KBPH/contagious-canine-cough-risk-assessment.
The risk assessment campaign will be supported with 'Does your dog ...' posters for vets, information and advice for dog owners on the website and a social media campaign encouraging dog owners to spread the information to other dog owners.
Carley Chutter, Nobivac(r) Product Manager at MSD Animal Health said: "With so many new dog owners now socialising more, taking their dogs on holiday and even considering taking their dogs into the office, protecting their dogs as they socialise is vital.
"Currently only an estimated 1 in 3 vaccinated dogs in the UK are also covered against Bordetella2 so the 'Ask us to protect your dog' resources offers the chance for practices to start the conversation about protection with clients.
"A common barrier to vaccinating against CCC is the belief that it is only necessary for dogs going into kennels, rather than all social dogs. Most dogs meet others, however, while out walking, during training, or while attending the vets, CCC is infectious even at low levels. Indeed, dogs can be asymptomatic but infectious.
"So, improving protection levels against this disease which is distressing for both the owner and dog, is important in both reducing the risk of outbreaks and the need for antibiotic treatment."
Nobivac(r) Respira Bb injectable vaccine against Bordetella bronchiseptica, gives 12 months protection when used as a single-dose booster in dogs previously vaccinated with Nobivac(r) KC. Dogs not previously vaccinated against Bordetella bronchiseptica require two doses administered four weeks apart. Duration of immunity is 7 months after the primary course and 12 months after a booster with Nobivac(r) Respira Bb. It may also be given 12 months after a primary course in cases where the 7 months dose is missed.
To support the use of Nobivac(r) Respira Bb a range of tools are available to practices and further information can be found at www.nobivacrespiraBb.co.uk, or contact your MSD Animal Health account manager.